Tech Company Financing Transactions

Lenoss Medical Funding Round

On 12/18/2023, Lenoss Medical secured investment from Xcellerant Ventures.

Transaction Overview

Company Name
Announced On
12/18/2023
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors

Xcellerant Ventures (Lead Investor)

Proceeds Purpose
The company intends to use the funds to accelerate its OsteoPearl commercial and development strategies providing physicians a biological option for treating osteoporotic Vertebral Compression fractures.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
150 Chestnut St
Providence, RI 02903
USA
Email Address
Overview
Lenoss Medical engages in providing solutions that support the natural osseous healing process. They disrupt the treatment of spinal fractures with the osteopearl VBA system, a viable, minimally invasive, and cement-free technology that utilizes the natural healing properties of healthy bone.
Profile
Lenoss Medical LinkedIn Company Profile
Social Media
Lenoss Medical Company Twitter Account
Company News
Lenoss Medical News
Facebook
Lenoss Medical on Facebook
YouTube
Lenoss Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dom Messerli
  Dom Messerli LinkedIn Profile  Dom Messerli Twitter Account  Dom Messerli News  Dom Messerli on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/18/2023: Meltwater Group venture capital transaction
Next: 12/18/2023: Chefaa venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary